FDA clears labeling change for non-drowsy Claritin

Schering-Plough said that the FDA has approved additional labeling for Claritin, which clearly tells consumers that the non-drowsy over-the-counter medication relieves allergy symptoms caused by both indoor or perennial or year-round and outdoor or seasonal allergies.